The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates
Exploration of Targeted Anti-tumor Therapy · 20.02.2024 · 5 (1) · 120-134
DOI: 10.37349/etat.2024.00209 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Exploration of Targeted Anti-tumor Therapy, online erschienen am 20.02.2024. Verfasst von Agustiningsih Agustiningsih und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eijkman Research Center for Molecular Biology, National Research and Innovation Agency of Indonesia (BRIN), Jakarta Pusat 10340, Indonesia. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancers with high mortality rate. Among its various etiological factors, one of the major risk factors for HCC is a chronic infection of hepatitis B virus (HBV). HBV X protein (HBx) has been identified to play an important role in the HBV-induced HCC pathogenesis since it may interfere with several key regulators of many cellular processes. HBx localization within the cells may be beneficial to HBx multiple functions at different phases of HBV infection and associated hepatocarcinogenesis. HBx as a regulatory protein modulates cellular transcription, molecular signal transduction, cell cycle, apoptosis, autophagy, protein degradation pathways, and host genetic stability via interaction with various factors, including its association with various non-coding RNAs. A better understanding on the regulatory mechanism of HBx on various characteristics of HCC would provide an overall picture of HBV-associated HCC. This article addresses recent data on HBx role in the HBV-associated hepatocarcinogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eijkman Research Center for Molecular Biology, National Research and Innovation Agency of Indonesia (BRIN), Jakarta Pusat 10340, Indonesia.
- Post Graduate School, Faculty of Medicine, Universitas Hasanuddin, Makassar 90245, Indonesia.
- Liver Cancer Unit, Fondazione Italiana Fegato ONLUS, AREA Science Park, Basovizza, 34149 Trieste, Italy.
ORCID-Profile: Agustiningsih Agustiningsih, Muhammad Rezki Rasyak, Turyadi, Sri Jayanti, Caecilia Sukowati
Zitieren
APA
Agustiningsih, A., Rasyak, M. R., Turyadi, Jayanti, S., & Sukowati, C. (2024). The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates. Exploration of Targeted Anti-tumor Therapy, 5(1), 120-134. https://doi.org/10.37349/etat.2024.00209
Vancouver
Agustiningsih A, Rasyak MR, Turyadi, Jayanti S, Sukowati C. The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates. Exploration of Targeted Anti-tumor Therapy. 2024;5(1):120-134. doi:10.37349/etat.2024.00209
BibTeX
@article{Agustiningsih2024,
author = {Agustiningsih, Agustiningsih and Rasyak, Muhammad Rezki and Turyadi and Jayanti, Sri and Sukowati, Caecilia},
title = {The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates},
journal = {Exploration of Targeted Anti-tumor Therapy},
year = {2024},
volume = {5},
number = {1},
pages = {120--134},
doi = {10.37349/etat.2024.00209}
}
EUVIMED